Skip to main content

Pharma stocks underperform S&P 500 by 5% in next 6 months

Make a pick
user-generated· price

Pharma stocks underperform S&P 500 by 5% in next 6 months

Market overview

Investor sentiment in pharmaceutical companies will decline due to increased regulatory risk from potential drug pricing reforms. The sector will trail the broader market as pricing pressure looms.

price prediction market

Implied probability (Yes)
60%

Source: user-generated

More price markets

Browse all price markets →

No one's made a Conviction call on this yet. Be the first to call it →
Loading…